Netflix and pill: is there a role for volume-delinked subscription-style payments beyond antimicrobials?’

Figures & data

Table 1. Features of health technologies for which a ‘Netflix-model’ may be useful.

Feature of the technology	Antibiotics	Treatments for infectious diseases	Digital therapies	Cell and gene therapies
Benefits from rationed usage (stewardship)	Y	N	N	N
Positive externalities of no rationing (increased usage) on population health	N	Y	<depends on the therapy and indication>	N
High cost technology	Y	Y	<depends on the therapy and indication>	Y
Low marginal cost of production	Y	Y	Y	N
Low delivery cost to the healthcare service	Y	Y	Y	N

Key: Y= feature is present for this technology; N = feature is not present.